The Patent Finder

Terms ending in 2030

Baxalta Incorporated

Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,464,269Method of Enhancing Cell Growth Using Alkyl-Amine-N-Oxide (AANOX)
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,143,347Pegylation of Recombinant Blood Coagulation Factors in the Presence of Bound Antibodies
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,388,847Methods of Concentrating Shear-Sensitive Biopolymers
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,445,544Hydrolysable Polymeric FMOC-Linker
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,637,007Factor Viia-Polysialic Acid Conjugate Having Prolonged in Vivo Half-Life
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,173,597Modified Recombinant Factor VIII and Von Willebrand Factor and Methods of Use
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,288,101Method for the Specific Detection of Low Abundance RNA Species in a Biological Sample
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,216,793Detection of Antibody That Binds to Water Soluble Polymer-Modified Polypeptides
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,889,838Removal of Serine Proteases by Treatment with Finely Divided Silicon Dioxide
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,921,520Removal of Serine Proteases by Treatment with Finely Divided Silicon Dioxide
In force
 · Medium confidence
Takeda Pharmaceutical Company LimitedIn forceMedium confidence
49 more term ends in 2030 · Pro
10 of 59 patents shown. Soonest term end first, then patent number.
Pro members see all 59.
Upgrade to Pro
4 of these are in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited